Drug Profile
Thrombomodulin alfa
Alternative Names: MB-015; MR-33; TMD1-105; TrodulinLatest Information Update: 02 Feb 2004
Price :
$50
*
At a glance
- Originator Unknown
- Class Anti-inflammatories; Anticoagulants; Antifibrotics; Antithrombotics; Peptides; Platelet membrane glycoproteins; Recombinant proteins
- Mechanism of Action Protein C stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Thrombosis
- Discontinued Disseminated intravascular coagulation
Most Recent Events
- 02 Feb 2004 No development reported - Preclinical for Thrombosis in USA (unspecified route)
- 04 Dec 2002 Discontinued - Preregistration for Disseminated intravascular coagulation in Japan (unspecified route)
- 22 Jun 1998 Phase-III clinical trials for Disseminated intravascular coagulation in Japan (Unknown route)